Latest Articles
NICE Recommends Keytruda Combination for First-Line Treatment of Advanced Endometrial Cancer - NAVLIN DAILY
NICE Recommends Keytruda Combination for First-Line Treatment of Advanced Endometrial Cancer NAVLIN DAILY
Published: Aug. 6, 2025, 9:30 a.m.
Women with advanced cancer get fresh hope as new treatment approved on NHS - The Independent
Women with advanced cancer get fresh hope as new treatment approved on NHS The Independent
Published: Aug. 6, 2025, 6:18 a.m.
Treatment for advanced womb cancer ‘major step forward’ - The Irish News
Treatment for advanced womb cancer ‘major step forward’ The Irish News
Published: Aug. 5, 2025, 11:01 p.m.
Treatment for advanced womb cancer ‘major step forward’ - Express & Star
Treatment for advanced womb cancer ‘major step forward’ Express & Star
Published: Aug. 5, 2025, 11:01 p.m.
Women with advanced cancer get fresh hope as new treatment approved on NHS - inkl
Women with advanced cancer get fresh hope as new treatment approved on NHS inkl
Published: Aug. 5, 2025, 11:01 p.m.
New cancer treatment that slashes risk of death by a quarter gives fresh hope to thousands in 'major step forward' - The Sun
New cancer treatment that slashes risk of death by a quarter gives fresh hope to thousands in 'major step forward' The Sun
Published: Aug. 5, 2025, 11:01 p.m.
AstraZeneca’s New Study on Endometrial Cancer Treatment: Key Insights for Investors - TipRanks
AstraZeneca’s New Study on Endometrial Cancer Treatment: Key Insights for Investors TipRanks
Published: Aug. 1, 2025, 4:33 p.m.
CD276xCD3 bispecific antibody shows preclinical promise for the treatment of endometrial cancer - BioWorld MedTech
CD276xCD3 bispecific antibody shows preclinical promise for the treatment of endometrial cancer BioWorld MedTech
Published: Aug. 1, 2025, 1 p.m.
Hear from one woman who is forced to seek medical treatment abroad for endometriosis - Newstalk
Hear from one woman who is forced to seek medical treatment abroad for endometriosis Newstalk
Published: Aug. 1, 2025, 9:47 a.m.
Persistent gaps continue to hinder progress in endometriosis treatment, GlobalData says - The Pharma Letter
Persistent gaps continue to hinder progress in endometriosis treatment, GlobalData says The Pharma Letter
Published: July 31, 2025, 2:21 p.m.
Link copied to clipboard!